17:14 EDT Moleculin Biotech (MBRX) files to sell 64.86M shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBRX:
- Moleculin Biotech’s Strategic Expansion and Promising Data Support Buy Rating
- Moleculin Biotech Expands Global Phase 2B/3 Trial
- Moleculin Biotech accelerates recruitment in Phase 3 MIRACLE trial
- Moleculin Biotech Releases New Corporate Presentation
- Moleculin Biotech Begins Phase 2B/3 MIRACLE Trial Enrollment